In this issue:
Catheter ablation vs. antiarrhythmic drugs in AF
Early vs. delayed cardioversion in recent-onset AF
Antithrombotic therapy after ACS or PCI in AF
Outcomes in ischaemic vs. nonischaemic cardiomyopathy in AF
Real-world NOAC persistence in nonvalvular AF
LA roof ablation with cryoballoon technique in symptomatic persistent AF
Reduced-dose NOACs in AF
Dabigatran dual therapy after PCI for AF ±ACS
Stroke/bleeding risk after dabigatran dual vs. warfarin triple therapy in AF after PCI
LAA occlusion use in older cardiac surgery patients with preoperative AF
AF cardioversion in obese patients
Please login below to download this issue (PDF)